You can watch KTOVW and buy or sell other stocks, options, ETFs, and crypto commission-free!
Kitov Pharma Ltd. Warrants, also called Kitov Pharmaceuticals (Warrant), is a development stage pharmaceutical company, which engages in drug development. Read More It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.
Tel Aviv, Tel Aviv
52 Week High
52 Week Low
BRIEF-Kitov Announces Initiation Of Phase 1/2 Clinical Trial Of NT219 In Advanced Cancer Patients
July 9 (Reuters) - Kitov Pharma Ltd: * KITOV ANNOUNCES INITIATION OF PHASE 1/2 CLINICAL TRIAL OF NT219 IN ADVANCED CANCER PATIENTS * KITOV PHARMA LTD - PRELIM